United States

Albany Molecular Research Inc (AMRI.O)

AMRI.O on Nasdaq

10:23am EDT
Change (% chg)

$0.40 (+2.24%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for AMRI.O


Albany Molecular Research, Inc. is a contract research and manufacturing company. The Company operates through Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP) and Fine Chemicals (FC) segments. The DDS segment includes activities, such as drug lead discovery, optimization, drug... (more)


Beta: 1.12
Market Cap(Mil.): $765.04
Shares Outstanding(Mil.): 42.93
Dividend: --
Yield (%): --


  AMRI.O Industry Sector
P/E (TTM): -- 138.86 17.42
EPS (TTM): -1.79 -- --
ROI: -8.19 2.17 -5.45
ROE: -24.26 0.04 -4.73

BRIEF-Amri Q1 non-gaap earnings per share $0.13

* Albany Molecular Research Inc - company confirms 2017 financial guidance

May 09 2017

BRIEF-Albany Molecular Research enters into agreement with pharmaceutical group Ferrer, Accord Healthcare

* Albany Molecular Research Inc - entered into an agreement with pharmaceutical group Ferrer and Accord Healthcare, Inc.

Feb 21 2017

BRIEF-AMRI posts Q4 adj. earnings per share $0.34

* AMRI announces fourth quarter and full year 2016 results and provides 2017 outlook

Feb 21 2017

BRIEF-AMRI announces API agreement supply with Shire

* Has entered into a multi-year supply agreement for an undisclosed product with shire us manufacturing Source text for Eikon: Further company coverage:

Nov 29 2016

More From Around the Web

Earnings vs. Estimates